ClinicalTrials.gg
RecruitingNCT07169474Updated Nov 25, 2025

Treatment of Peritrapezial Osteoarthritis With Isolated Trapeziometacarpal Arthroplasty in 300 Patients

An interventional study of Isolated trapeziometacarpal arthroplasty with double mobility in Trapeziometacarpal Osteoarthritis, sponsored by Clinique Saint Jean, France. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-11-25.

Sponsored by Clinique Saint Jean, France · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Sep 2025; still recruiting 1 year 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 136 studies in Osteoarthritis with a site in France — 25 open to participants now, 38 under way, 2 of them phase 3. Osteoarthritis · France.

Planned enrollment
13th of 86
300 · median 90
Started
2025
with 5 others
No phase
48 of 136
12 open now
Primary completion
2027-07
later than 17 of 37 live
Registered
127th of 136
by date

Among the 136 studies in Osteoarthritis with a site in France, this one is the 13th largest by planned enrollment of the 86 interventional ones that give a count, is one of 6 that started in 2025, is one of 48 with no phase, reaches primary completion later than 17 of the 37 other live ones, and was the 127th registered.

Osteoarthritis

2,978 studies on the registry are indexed under Osteoarthritis; 438 are open to participants now.

Browse Osteoarthritis studies →

Open to participants now

25 of the 136 studies in Osteoarthritis with a site in France are open now. Recruiting first, the newest first:

19 more — sign in →

All 25 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 285 Osteoarthritis studies recruiting now, 158 (55%) set no upper age limit and 70 (25%) stop at 75 or younger; 22 take children under 18; 31 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 136 studies in Osteoarthritis with a site in France, or all of them as a file.
02

Study summary

The aim of this clinical trial is to assess the functional outcomes of isolated trapeziometacarpal joint arthroplasty in adult patients requiring surgical management of trapeziometacarpal osteoarthritis, with or without associated symptoms.

The primary endpoint is the evolution of the Quick DASH functional score between inclusion (preoperative) and one year postoperatively.

The study design is a follow-up study of a multicenter cohort.

03

Conditions studied

  • Trapeziometacarpal Osteoarthritis

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:- Patients over 18 years of age who are members or beneficiaries of french social security

  • Patient requiring surgical management
  • Clinical and radiographic diagnosis of peri-trapezial osteoarthritis in the 1 or 2 joints:

TM osteoarthritis: glickel sign + grinding test STT osteoarthritis: pain on wrist mobilization in flexion-extension and prono-supination

  • TM (Eaton-Littler stages II to III) and STT (Crosby stages II and III) radiographic osteoarthritis
  • Persistent pain and functional limitations despite conservative treatment for at least 6 months (combining intermittent immobilization of wrist and thumb + joint infiltration of the 2 joints)
  • Ability to understand and sign the form.

Exclusion Criteria:

  • History of surgery on the affected thumb.
  • Systemic inflammatory diseases (e.g. rheumatoid arthritis).
  • Active infection or history of joint infection of the upper limb.
  • Inability to participate in post-operative follow-up.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    Isolated trapeziometacarpal arthroplasty

    Isolated TM arthroplasty with double mobility in all cases, using a MAIA (Laboratoire LEPINE) or TOUCH (Laboratoire KERIMEDICAL) prosthesis, depending on the surgeons' habits. Participating surgeons will follow a common operating protocol to ensure consistency of procedures.

    Procedure: Isolated trapeziometacarpal arthroplasty with double mobility

Interventions

  • ProcedureIsolated trapeziometacarpal arthroplasty with double mobility

    Isolated trapeziometacarpal arthroplasty with double mobility in all cases, using a MAIA or TOUCH prosthesis depending on the operator's habits.

06

What researchers measure

Primary outcomes

  1. Disabilities of the Arm, Shoulder and Hand (Quick Dash) functional score

    Change in Quick DASH functional score between inclusion (preoperative) and one year postoperatively, from 0 = no disability to 100 = maximum disability.

    Time frame: One year

Secondary outcomes

  1. Patient satisfaction

    Likert satisfaction scale at 3 months, 6 months and 12 months post-operative. Chossing between very satisfied , Satisfied , No opinion , Dissatisfied or Very dissatisfied

    Time frame: 3 months, 6 months and 12 months post-operative

  2. Complication or surgery

    Need for repeat surgery and any post-operative complication during 12-month follow-up. Need for additional surgery on STT joint (= if pain on palpation and flexion/extension mobilization)

    Time frame: One year

  3. Radiographic evaluation

    Radiographic evaluation: absence of prosthesis complications

    Time frame: one year

  4. Pain in the operated hand

    Visual Analogue Scale (VAS) for pain preoperatively at 3 months, 6 months and 12 months postoperatively, from 0 (no pain) to 10 (maximum pain).

    Time frame: 3 months, 6 months and 12 months postoperatively

  5. Pinch and grip force

    Pinch and grip force measured with dynamometer preoperatively, at 3 months, 6 months and 12 months postoperatively.

    Time frame: 3 months, 6 months and 12 months postoperatively

  6. Range of motion of the thumb

    Range of motion of the thumb measured relative to the 2nd metacarpal: antepulsion, retropulsion, abduction and adduction preoperatively, at 3 months, 6 months and 12 months postoperatively

    Time frame: 3 months, 6 months and 12 months postoperatively

  7. Wrist range of motion

    Wrist range of motion: flexion, extension, radial tilt and ulnar tilt preoperatively, at 3 months, 6 months and 12 months postoperatively

    Time frame: 3 months, 6 months and 12 months postoperatively

  8. Amplitude of possible metacarpophalangeal hyperextension

    Amplitude of possible metacarpophalangeal hyperextension preoperatively at 3 months, 6 months and 12 months postoperatively

    Time frame: preoperatively at 3 months, 6 months and 12 months postoperatively

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2025 (actual). Primary completion is estimated for Jul 2027, 22 months after the start.

Of 578 non-industry interventional studies with no phase under Osteoarthritis, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 51. This study's planned 22 months is below that.

Counting every sponsor, half of 713 studies reached it within 28 months; a quarter within 11 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 29, 2025
First posted
Sep 11, 2025
StartActual
Sep 9, 2025
Primary completionEst.
Jul 30, 2027
CompletionEst.
Jul 30, 2027
Last update
Nov 25, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 25, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07169474
Lead sponsor
Clinique Saint Jean, France
Responsible party
Benjamin DEGEORGE (Surgeon, Clinique Saint Jean, France) — Principal investigator
First posted
Sep 11, 2025
Start date
Sep 9, 2025
Primary completion
Jul 30, 2027 (estimated)
Completion
Jul 30, 2027 (estimated)
Last update
Nov 25, 2025

Study contacts

Cecile Spirito
Contact
cecile.spirito@capsante.fr
0033467413399
benjamin Degeorge
principal investigator · Clinique Saint jean sud de france

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion